Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Neuroendocrine Cancer Headlining the News
MARCH 2024 07/03/2023 - Hollywood producer who worked on action films starring Bruce Willis and John Travolta passes away after neuroendocrine cancer battle Sean Stone dies aged 31: Hollywood producer who worked on action films starring Bruce Willis and John Travolta...
Neuroendocrine Cancer Surgical Specialty Lead (SSL) Appointed
- As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, we are delighted to announce the appointment of a neuroendocrine cancer Surgical Specialty Lead (SSL). This is the first time such a role has been established specifically for neuroendocrine cancer,...
NETTER-2 Study Results: Looking Beyond The headlines.
The latest breakthrough in neuroendocrine cancer treatment comes from the NETTER-2 trial, where Lutetium (177Lu) oxodotreotide, a radio-labeled somatostatin analog, has shown remarkable success in treating high-grade advanced gastroenteropancreatic neuroendocrine...